CapsoVision (NASDAQ:CV) Stock Price Down 3.1% – Here’s What Happened

CapsoVision, Inc. (NASDAQ:CV)’s stock price was down 3.1% during trading on Thursday . The company traded as low as $11.58 and last traded at $11.77. Approximately 12,597 shares traded hands during mid-day trading, a decline of 92% from the average daily volume of 163,405 shares. The stock had previously closed at $12.15.

Analyst Ratings Changes

Several research analysts recently issued reports on CV shares. Zacks Research upgraded shares of CapsoVision to a “hold” rating in a research report on Wednesday, November 5th. Roth Capital set a $7.00 price objective on CapsoVision in a report on Tuesday, November 4th. Benchmark reaffirmed a “speculative buy” rating on shares of CapsoVision in a research note on Friday, November 14th. Finally, Weiss Ratings reissued a “sell (e)” rating on shares of CapsoVision in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, CapsoVision currently has a consensus rating of “Moderate Buy” and an average target price of $6.00.

CapsoVision Trading Up 25.4%

The company has a fifty day moving average of $6.48.

CapsoVision (NASDAQ:CV) last released its quarterly earnings results on Thursday, November 13th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.03). The business had revenue of $3.54 million during the quarter.

Hedge Funds Weigh In On CapsoVision

An institutional investor recently bought a new position in CapsoVision stock. New York State Common Retirement Fund acquired a new position in CapsoVision, Inc. (NASDAQ:CV) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 7,114 shares of the company’s stock, valued at approximately $34,000.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.